Skip to main content

Advertisement

SpringerLink
Log in

Intensive Care Practice in the Cancer Patient Population: Special Considerations and Challenges

  • Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)
  • Published:
Current Anesthesiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

As the modern era of cancer treatment improves survival for patients, intensive care units (ICUs) play an increasing role in their management to support patients during cancer therapy. This review seeks to summarise some important changes and persisting challenges in the care of this complex patient group.

Recent Findings

Technological advances and improvements in overall cancer treatment have challenged historical approaches to suitability for admission and provision of ICU support. In particular, old paradigms (such as not admitting hematological malignancy patients to the ICU for mechanical ventilation) no longer apply in the modern era. Improved peri-operative care and advances in surgical techniques rely on the availability of the ICU for post-operative support, particularly after increasingly complex surgical procedures are embarked on with curative intent.

Summary

Intensive care is an integral part of the multidisciplinary care required for cancer patients. Challenges, including ethical aspects and difficulties with risk stratification, remain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Article Open access 01 February 2016

Peter Schellongowski, Michael Kiehl, … On Behalf of Intensive Care in Hematologic-Oncologic Patients (iCHOP)

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96. https://doi.org/10.3322/ca.2007.0010.

    Article  PubMed  Google Scholar 

  2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581–92. https://doi.org/10.1093/annonc/mdl498.

    Article  CAS  PubMed  Google Scholar 

  3. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117–28. https://doi.org/10.1093/jnci/djq495.

    Article  PubMed  PubMed Central  Google Scholar 

  4. •• Shimabukuro-Vornhagen A, Boll B, Kochanek M, Azoulay E, von Bergwelt-Baildon MS. Critical care of patients with cancer. CA Cancer J Clin. 2016;66:496–517. https://doi.org/10.3322/caac.21351.

    Article  PubMed  Google Scholar 

  5. Ahmed S, Oropello JM. Critical care issues in oncological surgery patients. Crit Care Clin. 2010;26(1):93–106. https://doi.org/10.1016/j.ccc.2009.10.004.

    Article  PubMed  Google Scholar 

  6. •• Richards S, Wibrow B, Anstey M, Sidiqi H, Chee A, Ho KM. Determinants of 6-month survival of critically ill patients with an active hematologic malignancy. J Crit Care. 2016;36:252–8. https://doi.org/10.1016/j.jcrc.2016.08.022A modern (2016) era publication describing contemporary outcomes and prognostic factors in critically ill patients with hematological malignancy.

    Article  PubMed  Google Scholar 

  7. Bos MM, Verburg IW, Dumaij I, Stouthard J, Nortier JW, Richel D, et al. Intensive care admission of cancer patients: a comparative analysis. Cancer medicine. 2015;4(7):966–76. https://doi.org/10.1002/cam4.430.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Puxty K, McLoone P, Quasim T, Sloan B, Kinsella J, Morrison DS. Risk of critical illness among patients with solid cancers: a population-based observational study. JAMA oncology. 2015;1(8):1078–85. https://doi.org/10.1001/jamaoncol.2015.2855.

    Article  PubMed  Google Scholar 

  9. Bos MM, de Keizer NF, Meynaar IA, Bakhshi-Raiez F, de Jonge E. Outcomes of cancer patients after unplanned admission to general intensive care units. Acta Oncol.(Stockholm, Sweden). 2012;51(7):897–905. https://doi.org/10.3109/0284186x.2012.679311.

    Article  Google Scholar 

  10. Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, et al. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med. 2010;38(1):9–15. https://doi.org/10.1097/CCM.0b013e3181c0349e.

    Article  PubMed  Google Scholar 

  11. •• Schellongowski P, Sperr WR, Wohlfarth P, Knoebl P, Rabitsch W, Watzke HH et al. Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. ESMO open. 2016;1(5):e000018. doi: https://doi.org/10.1136/esmoopen-2015-000018. Describes difficulties in prognostication and resolving differences in opinion in the management of patients with cancer in the ICU.

  12. Maude SL, Barrett D, Teachey DT, Grupp SA. Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J. (Sudbury, Mass). 2014;20(2):119–22. https://doi.org/10.1097/ppo.0000000000000035.

    Article  CAS  Google Scholar 

  13. Bos MM, Bakhshi-Raiez F, Dekker JW, de Keizer NF, de Jonge E. Outcomes of intensive care unit admissions after elective cancer surgery. Eur J Surg Oncol. 2013;39(6):584–92. https://doi.org/10.1016/j.ejso.2013.02.014.

    Article  CAS  PubMed  Google Scholar 

  14. Soares M, Fontes F, Dantas J, Gadelha D, Cariello P, Nardes F, et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care. 2004;8(4):R194–203. https://doi.org/10.1186/cc2870.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Maschmeyer G, Bertschat FL, Moesta KT, Hausler E, Held TK, Nolte M, et al. Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period. Eur. J. Cancer (Oxford, England: 1990). 2003;39(6):783–92.

    Article  CAS  Google Scholar 

  16. Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28(5):1322–8.

    Article  CAS  PubMed  Google Scholar 

  17. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992;67(2):117–22.

    Article  CAS  PubMed  Google Scholar 

  18. • Swart M, Carlisle JB, Goddard J. Using predicted 30 day mortality to plan postoperative colorectal surgery care: a cohort study. Br. J. Anaesth. 2017;118(1):100–4. https://doi.org/10.1093/bja/aew402A recent (2017) centre study describing negative outcomes for higher-risk surgical patients not admitted to a high-dependency unit.

    Article  CAS  PubMed  Google Scholar 

  19. Wunsch H, Gershengorn HB, Cooke CR, Guerra C, Angus DC, Rowe JW, et al. Use of intensive care services for medicare beneficiaries undergoing major surgical procedures. Anesthesiology. 2016;124(4):899–907. https://doi.org/10.1097/aln.0000000000001024.

    Article  PubMed  Google Scholar 

  20. Kahan BC, Koulenti D, Arvaniti K, Beavis V, Campbell D, Chan M, et al. Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries. Intensive Care Med. 2017;43(7):971–9. https://doi.org/10.1007/s00134-016-4633-8.

    Article  PubMed  Google Scholar 

  21. Gillies MA, Pearse RM. Intensive care after high-risk surgery: What’s in a name? Anesthesiology. 2016;124(4):761–2. https://doi.org/10.1097/aln.0000000000001025.

    Article  PubMed  Google Scholar 

  22. Puxty K, McLoone P, Quasim T, Sloan B, Kinsella J, Morrison DS. Characteristics and outcomes of surgical patients with solid cancers admitted to the intensive care unit. JAMA Surg. 2018;153(9):834–40. https://doi.org/10.1001/jamasurg.2018.1571.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kapoor S, Bassily-Marcus A, Alba Yunen R, Tabrizian P, Semoin S, Blankush J, et al. Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. World J Crit Care Med. 2017;6(2):116–23. https://doi.org/10.5492/wjccm.v6.i2.116.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Mogal HD, Levine EA, Fino NF, Obiora C, Shen P, Stewart JH, et al. Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement. Ann Surg Oncol. 2016;23(5):1486–95. https://doi.org/10.1245/s10434-015-4963-8.

    Article  PubMed  Google Scholar 

  25. Levine EA, Stewart JH, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573–85. https://doi.org/10.1016/j.jamcollsurg.2013.12.013.

    Article  PubMed  Google Scholar 

  26. Cooksley TJ, Haji-Michael P. Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2011;9:169. https://doi.org/10.1186/1477-7819-9-169.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, et al. Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol. 2013;20(11):3497–503. https://doi.org/10.1245/s10434-013-3053-z.

    Article  PubMed  Google Scholar 

  28. Malfroy S, Wallet F, Maucort-Boulch D, Chardonnal L, Sens N, Friggeri A, et al. Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score. Surg Oncol. 2016;25(1):6–15. https://doi.org/10.1016/j.suronc.2015.11.003.

    Article  PubMed  Google Scholar 

  29. Nadeem A, Al-Tarifi A. ICU outcome of patients undergoing cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: a single-center study. Crit Care. 2015;19(1):P376. https://doi.org/10.1186/cc14456.

    Article  PubMed Central  Google Scholar 

  30. Lopez-Basave HN, Morales-Vasquez F, Mendez-Herrera C, Namendys-Silva SA, Luna-Ortiz K, Calderillo-Ruiz G, et al. Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary? J Oncol. 2014;2014:307317. https://doi.org/10.1155/2014/307317.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Baratti D, Kusamura S, Iusco D, Bonomi S, Grassi A, Virzi S, et al. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum. 2014;57(7):858–68. https://doi.org/10.1097/dcr.0000000000000149.

    Article  CAS  PubMed  Google Scholar 

  32. Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. 2014;18(5):1024–31. https://doi.org/10.1007/s11605-014-2477-5.

    Article  PubMed  Google Scholar 

  33. Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215(3):412–7. https://doi.org/10.1016/j.jamcollsurg.2012.04.023.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2010;28(1):63–8. https://doi.org/10.1200/jco.2009.23.9285.

    Article  Google Scholar 

  35. Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10(8):863–9.

    Article  CAS  PubMed  Google Scholar 

  36. Kao SC, Butow P, Bray V, Clarke SJ, Vardy J. Patient and oncologist estimates of survival in advanced cancer patients. Psychooncology. 2011;20(2):213–8. https://doi.org/10.1002/pon.1727.

    Article  PubMed  Google Scholar 

  37. O'Brien JM Jr, Aberegg SK, Ali NA, Diette GB, Lemeshow S. Results from the national sepsis practice survey: predictions about mortality and morbidity and recommendations for limitation of care orders. Crit Care. 2009;13(3):R96. https://doi.org/10.1186/cc7926.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, et al. A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med. 2007;356(5):469–78. https://doi.org/10.1056/NEJMoa063446.

    Article  CAS  PubMed  Google Scholar 

  39. Soares M, Depuydt PO, Salluh JI. Mechanical ventilation in cancer patients: clinical characteristics and outcomes. Crit Care Clin. 2010;26(1):41–58. https://doi.org/10.1016/j.ccc.2009.09.005.

    Article  PubMed  Google Scholar 

  40. Schnell D, Lemiale V, Azoulay E. Non-invasive mechanical ventilation in hematology patients: let's agree on several things first. Crit Care. 2012;16(6):175. https://doi.org/10.1186/cc11830.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Pastores SM, Voigt LP. Acute respiratory failure in the patient with cancer: diagnostic and management strategies. Crit Care Clin. 2010;26(1):21–40. https://doi.org/10.1016/j.ccc.2009.10.001.

    Article  CAS  PubMed  Google Scholar 

  42. Azoulay E, Soares M, Darmon M, Benoit D, Pastores S, Afessa B. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care. 2011;1(1):5. https://doi.org/10.1186/2110-5820-1-5.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Maschmeyer G, Carratala J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015;26(1):21–33. https://doi.org/10.1093/annonc/mdu192.

    Article  CAS  PubMed  Google Scholar 

  44. Corley A, Rickard CM, Aitken LM, Johnston A, Barnett A, Fraser JF, et al. High-flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database Syst. Rev. 2017;5:CD010172. https://doi.org/10.1002/14651858.CD010172.pub2.

    Article  PubMed  Google Scholar 

  45. Frat JP, Ragot S, Thille AW. High-flow nasal cannula oxygen in respiratory failure. N Engl J Med. 2015;373(14):1374–5. https://doi.org/10.1056/NEJMc1508390.

    Article  PubMed  Google Scholar 

  46. Lemiale V, Resche-Rigon M, Mokart D, Pene F, Rabbat A, Kouatchet A, et al. Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en reanimation onco-hematologique (Grrr-OH) study. Ann Intensive Care. 2015;5(1):28. https://doi.org/10.1186/s13613-015-0070-z.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Soares M, Salluh JI, Azoulay E. Noninvasive ventilation in patients with malignancies and hypoxemic acute respiratory failure: a still pending question. J Crit Care. 2010;25(1):37–8. https://doi.org/10.1016/j.jcrc.2009.04.001.

    Article  PubMed  Google Scholar 

  48. Ozyilmaz E, Ugurlu AO, Nava S. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med. 2014;14:19. https://doi.org/10.1186/1471-2466-14-19.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med. 2007;35(3):808–14. https://doi.org/10.1097/01.CCM.0000256846.27192.7A.

    Article  PubMed  Google Scholar 

  50. Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore). 2004;83(6):360–70.

    Article  PubMed  Google Scholar 

  51. Kiehl MG, Beutel G, Boll B, Buchheidt D, Forkert R, Fuhrmann V, et al. Consensus statement for cancer patients requiring intensive care support. Ann Hematol. 2018;97(7):1271–82. https://doi.org/10.1007/s00277-018-3312-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Vincent F, Soares M, Mokart D, Lemiale V, Bruneel F, Boubaya M, et al. In-hospital and day-120 survival of critically ill solid cancer patients after discharge of the intensive care units: results of a retrospective multicenter study-a Groupe de recherche respiratoire en reanimation en Onco-Hematologie (Grrr-OH) study. Ann Intensive Care. 2018;8(1):40. https://doi.org/10.1186/s13613-018-0386-6.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Darmon M, Thiery G, Ciroldi M, de Miranda S, Galicier L, Raffoux E, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med. 2005;33(11):2488–93.

    Article  PubMed  Google Scholar 

  54. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52(4):e56–93. https://doi.org/10.1093/cid/cir073.

    Article  PubMed  Google Scholar 

  55. Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect. 2012;18(Suppl 7):53–67. https://doi.org/10.1111/1469-0691.12041.

    Article  CAS  PubMed  Google Scholar 

  56. Gutierrez C, McEvoy C, Mead E, Stephens RS, Munshi L, Detsky ME, et al. Management of the critically ill adult chimeric antigen receptor-T cell therapy patient: a critical care perspective. Crit Care Med. 2018;46(9):1402–10. https://doi.org/10.1097/ccm.0000000000003258.

    Article  PubMed  Google Scholar 

  57. Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA, Malin JL, et al. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2012;30(35):4387–95. https://doi.org/10.1200/jco.2012.43.6055.

    Article  Google Scholar 

  58. Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2010;28(29):4457–64. https://doi.org/10.1200/jco.2009.26.3863.

    Article  Google Scholar 

  59. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42. https://doi.org/10.1056/NEJMoa1000678.

    Article  CAS  PubMed  Google Scholar 

  60. Cheung MC, Earle CC, Rangrej J, Ho TH, Liu N, Barbera L, et al. Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer. 2015;121(18):3307–15. https://doi.org/10.1002/cncr.29485.

    Article  PubMed  Google Scholar 

  61. Zhang B, Wright AA, Huskamp HA, Nilsson ME, Maciejewski ML, Earle CC, et al. Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med. 2009;169(5):480–8. https://doi.org/10.1001/archinternmed.2008.587.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Khandelwal N, Kross EK, Engelberg RA, Coe NB, Long AC, Curtis JR. Estimating the effect of palliative care interventions and advance care planning on ICU utilization: a systematic review. Crit Care Med. 2015;43(5):1102–11. https://doi.org/10.1097/ccm.0000000000000852.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Scheunemann LP, Cunningham TV, Arnold RM, Buddadhumaruk P, White DB. How clinicians discuss critically ill patients' preferences and values with surrogates: an empirical analysis. Crit Care Med. 2015;43(4):757–64. https://doi.org/10.1097/ccm.0000000000000772.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Thiery G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Levy V, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2005;23(19):4406–13. https://doi.org/10.1200/jco.2005.01.487.

    Article  Google Scholar 

  65. Shrime MG, Ferket BS, Scott DJ, Lee J, Barragan-Bradford D, Pollard T, et al. Time-limited trials of intensive care for critically ill patients with cancer: how long is long enough? JAMA Oncol. 2016;2(1):76–83. https://doi.org/10.1001/jamaoncol.2015.3336.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Breen CM, Abernethy AP, Abbott KH, Tulsky JA. Conflict associated with decisions to limit life-sustaining treatment in intensive care units. J Gen Intern Med. 2001;16(5):283–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Azoulay E, Timsit JF, Sprung CL, Soares M, Rusinova K, Lafabrie A, et al. Prevalence and factors of intensive care unit conflicts: the conflicus study. Am J Respir Crit Care Med. 2009;180(9):853–60. https://doi.org/10.1164/rccm.200810-1614OC.

    Article  PubMed  Google Scholar 

  68. Swetz KM, Crowley ME, Hook C, Mueller PS. Report of 255 clinical ethics consultations and review of the literature. Mayo Clin Proc. 2007;82(6):686–91.

    Article  PubMed  Google Scholar 

  69. • Bosslet GT, Pope TM, Rubenfeld GD, Lo B, Truog RD, Rushton CH, et al. An official ATS/AACN/ACCP/ESICM/SCCM policy statement: responding to requests for potentially inappropriate treatments in intensive care units. Am J Respir Crit Care Med. 2015;191(11):1318–30. https://doi.org/10.1164/rccm.201505-0924STA consensus statement from the critical care organisations describing how to navigate potentially inappropriate care in the ICU.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, Royal Melbourne Hospital, Grattan St., Parkville, Victoria, 3050, Australia

    Jai N. Darvall, Ned Douglas & James R. Anstey

  2. Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia

    Jai N. Darvall

  3. Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia

    Jai N. Darvall

  4. Department of Intensive Care, Alfred Hospital, Melbourne, Australia

    Timothy Byrne

  5. School of Public Health and Preventative Medicine, Monash University, Clayton, Australia

    Timothy Byrne

Authors
  1. Jai N. Darvall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ned Douglas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James R. Anstey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jai N. Darvall.

Ethics declarations

Conflict of Interest

Jai N. Darvall, Timothy Byrne, Ned Douglas, and James Anstey declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Cancer Anesthesia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Darvall, J.N., Byrne, T., Douglas, N. et al. Intensive Care Practice in the Cancer Patient Population: Special Considerations and Challenges. Curr Anesthesiol Rep 8, 439–447 (2018). https://doi.org/10.1007/s40140-018-0293-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40140-018-0293-2

Keywords

Search

Navigation